CTCs could guide cancer therapy

Area of Science:

• Oncology
• Biotechnology
• Genetics

Background:

• Circulating tumor cells (CTCs) are crucial biomarkers for cancer progression and treatment response.
• Current methods for CTC isolation and analysis present challenges in efficiency and scalability.

Purpose of the Study:

• To develop and validate a microchip-based platform for capturing and culturing CTCs.
• To enable comprehensive genetic analysis and drug sensitivity testing on viable CTCs.

Main Methods:

• A novel microfluidic device was employed for the enrichment and isolation of CTCs from patient samples.
• Captured CTCs were cultured in vitro to generate sufficient cell numbers for downstream analyses.
• High-throughput sequencing and targeted drug screening assays were performed on the cultured CTCs.

Main Results:

• The microchip device successfully captured and cultured viable CTCs, preserving their genetic integrity.
• New tumor-specific mutations were identified, revealing previously unknown driver alterations.
• Drug testing demonstrated that identified mutations were susceptible to specific targeted therapeutic agents.

Conclusions:

• Microchip-based CTC capture and culture offer a powerful tool for personalized cancer medicine.
• This technology facilitates the discovery of actionable tumor mutations and guides targeted therapy selection.
• The platform holds significant potential for improving patient outcomes through precision oncology.